Max heads up the FP&A function focusing on financial modeling, budgeting and forecasting. Prior to joining the Firm, he was an Operations Associate at Sculpta Bio, where he was responsible for financial planning and market analysis. Earlier in his career, he served as a Venture Capital Associate at Medical Excellence Capital. Max began his professional journey at Regeneron Pharmaceuticals as an R&D Specialist in viral vector technologies.  He also worked as a Research Fellow at the National Institutes of Health. Max holds a BS in Molecular Genetics from the University of Rochester and an MBA from The University of Chicago Booth School of Business.